- Home
- CVAC vs CHI Comparison
CVAC vs CHI Comparison
Compare CVAC & CHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- CHI
- Stock Information
- Founded
- CVAC 2000
- CHI 2002
- Country
- CVAC Germany
- CHI United States
- Employees
- CVAC N/A
- CHI N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- CHI Investment Managers
- Sector
- CVAC Health Care
- CHI Finance
- Exchange
- CVAC Nasdaq
- CHI Nasdaq
- Market Cap
- CVAC 818.8M
- CHI 762.2M
- IPO Year
- CVAC 2020
- CHI N/A
- Fundamental
- Price
- CVAC $2.77
- CHI $9.59
- Analyst Decision
- CVAC Hold
- CHI
- Analyst Count
- CVAC 3
- CHI 0
- Target Price
- CVAC $10.00
- CHI N/A
- AVG Volume (30 Days)
- CVAC 620.8K
- CHI 186.2K
- Earning Date
- CVAC 05-22-2025
- CHI 01-01-0001
- Dividend Yield
- CVAC N/A
- CHI 9.90%
- EPS Growth
- CVAC N/A
- CHI N/A
- EPS
- CVAC N/A
- CHI N/A
- Revenue
- CVAC $70,565,734.00
- CHI N/A
- Revenue This Year
- CVAC $742.57
- CHI N/A
- Revenue Next Year
- CVAC N/A
- CHI N/A
- P/E Ratio
- CVAC N/A
- CHI N/A
- Revenue Growth
- CVAC 75.11
- CHI N/A
- 52 Week Low
- CVAC $2.22
- CHI $9.70
- 52 Week High
- CVAC $5.28
- CHI $11.61
- Technical
- Relative Strength Index (RSI)
- CVAC 38.24
- CHI 27.04
- Support Level
- CVAC $2.78
- CHI $9.97
- Resistance Level
- CVAC $3.33
- CHI $10.24
- Average True Range (ATR)
- CVAC 0.15
- CHI 0.17
- MACD
- CVAC -0.00
- CHI 0.00
- Stochastic Oscillator
- CVAC 8.20
- CHI 16.67
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About CHI Calamos Convertible Opportunities and Income Fund
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND operates as a closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in convertible securities and high-yield securities.